Management of Non-Muscle Invasive Bladder Cancer

This video goes over the workup and management of non-muscle invasive bladder cancer (NMIBC). Daniel Reznicek, a urologist in Bellingham, WA goes over through the American Urological Association Guidelines on non-muscle invasive bladder cancer for patients. See the full guidelines here: https://www.auanet.org/guidelines/bladder-cancer-non-muscle-invasive-guideline 07:05 - Risk Category Descriptions 10:17 - Low Risk NMIBC Management 15:26 - Intermediate Risk NMIBC Management 19:15 - High Risk NMIBC Management This video outlines criteria for low risk, intermediate risk, and high risk as outlined by the AUA guideline and goes through the surveillance and treatment options based on risk. Other resources: NCCN Patient Guidelines for Urothelial Cancer: https://www.nccn.org/patients/guidelines/content/PDF/bladder-patient.pdf Urothelial Field Effect Study: https://clincancerres.aacrjournals.org/content/11/18/6512 Non-Muscle Invasive Bladder Cancer risk of progression: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984851/#CR5 https://www.ncbi.nlm.nih.gov/pubmed/10954628/ Use of BCG therapy in NMIBC: https://pubmed.ncbi.nlm.nih.gov/17604943/